SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Nature Communications, 2021


The causative agent of the COVID-19 pandemic, SARS-CoV-2, is steadily mutating during continuous transmission among humans. Such mutations can occur in the spike (S) protein that binds to the ACE2 receptor and is cleaved by TMPRSS2. However, whether S mutations affect SARS-CoV-2 cell entry remains unknown. Here, we show that naturally occurring S mutations can reduce or enhance cell entry via ACE2 and TMPRSS2. A SARS-CoV-2 S-pseudotyped lentivirus exhibits substantially lower entry than that of SARS-CoV S. Among S variants, the D614G mutant shows the highest cell entry, as supported by structural and binding analyses. Nevertheless, the D614G mutation does not affect neutralization by antisera against prototypic viruses. Taken together, we conclude that the D614G mutation increases cell entry by acquiring higher affinity to ACE2 while maintaining neutralization susceptibility. Based on these findings, further worldwide surveillance is required to understand SARS-CoV-2 transmissibility among humans.

In this paper, GTX632604 has been tested on several variants. As the epitope of the clone is in the S2 region and has a lower mutation rate, it is suitable for detecting S1/RBD mutants.

>> Besuchen Sie unseren Webshop

>> Artikel anzeigen


Bei Fragen stehen wir Ihnen jederzeit gerne zur Verfügung.

+49 (0)89 3799666-6
+49 (0)89 3799666-99